Anna Enjuanes

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.

Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.

Journal: Leukemia
Published: January 03, 2025

Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL.

Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL.

Journal: HemaSphere
Published: March 25, 2024

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.

Journal: Blood advances
Published: March 06, 2023

Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO.

Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO.

Journal: British journal of haematology
Published: February 20, 2023

Unraveling the genetics of transformed splenic marginal zone lymphoma.

Unraveling the genetics of transformed splenic marginal zone lymphoma.

Journal: Blood advances
Published: November 29, 2022

Intravascular Large B-Cell Lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune Checkpoints.

Intravascular Large B-Cell Lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune Checkpoints.

Journal: The American journal of surgical pathology
Published: October 12, 2022

MYC and TP53 Alterations but Not MAPK Pathway Mutations Are Common Oncogenic Mechanisms in Follicular Dendritic Cell Sarcomas.

MYC and TP53 Alterations but Not MAPK Pathway Mutations Are Common Oncogenic Mechanisms in Follicular Dendritic Cell Sarcomas.

Journal: Archives of pathology & laboratory medicine
Published: June 23, 2022

Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma.

Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma.

Journal: Diagnostics (Basel, Switzerland)
Published: May 15, 2022

NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma.

NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma.

Journal: Hematological oncology
Published: May 05, 2022

Detection of early seeding of Richter transformation in chronic lymphocytic leukemia.

Detection of early seeding of Richter transformation in chronic lymphocytic leukemia.

Journal: Nature medicine
Published: November 10, 2021

Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma.

Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma.

Journal: British journal of haematology
Published: June 14, 2021

MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.

MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.

Journal: Haematologica
Published: September 24, 2020
Showing 1-12 of 35

Last Updated: 09/26/2026